OTC Glucose Monitor.

The article discusses the Dexcom Stelo, a glucose biosensor that was cleared by the FDA in March. This device, worn on the back of the upper arm, is designed for individuals with Type 2 diabetes or pre-diabetes who are not using insulin. The corresponding app provides users with real-time glucose level readouts, empowering them to make informed decisions about their health. The device aims to help users prevent the exacerbation of diabetes through simple monitoring techniques. [Extracted from the article]

Copyright of Time International (South Pacific Edition) is the property of TIME USA, LLC and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)